Antagonistic activities of some Bifidobacterium sp. strains isolated from resident infant gastrointestinal microbiota on Gram-negative enteric pathogens

Anaerobe

Volumn 39, Issue , 2016, Pages 39-44

  Delcaru, Cristina ^a,c   Alexandru, Ionela ^a   Podgoreanu, Paulina ^a   Cristea, Violeta Corina ^b   Bleotu, Coralia ^c   Chifiriuc, Mariana Carmen ^c   Bezirtzoglou, Eugenia ^d   Lazar, Veronica ^c  

^a Iancului Private Laboratory   (Romania)

^b Department of Microbiology Reference Laboratory Central Synevo ^*  (Romania)

^c UNIVERSITY OF BUCHAREST   (Romania)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Antagonistic relationships; Bifidobacterium sp; Disbiosis; Enteric pathogens; Lactobacillus sp; Normal microbiota; Probiotics

Indexed keywords

PROBIOTIC AGENT; VIRULENCE FACTOR;

ANTIBACTERIAL ACTIVITY; ANTIBIOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; BIFIDOBACTERIUM RUMINANTIUM; CHILD; CLINICAL ARTICLE; DIARRHEA; ENTEROINVASIVE ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA; YERSINIA ENTEROCOLITICA; BIOSYNTHESIS; DRUG EFFECTS; FECES; FEMALE; GROWTH, DEVELOPMENT AND AGING; LACTOBACILLUS; MALE; MICROBIOLOGY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

ANTIBIOSIS; BACTERIAL ADHESION; BIFIDOBACTERIUM; CHILD, PRESCHOOL; DIARRHEA; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS; MALE; PROBIOTICS; PSEUDOMONAS AERUGINOSA; SALMONELLA; VIRULENCE FACTORS; YERSINIA ENTEROCOLITICA;

EID: 84959419748     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2016.02.010     Document Type: Article

References (12)

1. Yuan-Kun L.E.E. Effects of diet on gut microbiota profile and the implications for health and disease. Biosci. Microbiota Food Health 2013, 32(1):1-12. 10.12938/bmfh.32.1.
2. Collado M.C., Isolauri E., Salminen S., Sanz Y. The impact of probiotic on gut health. Curr. Drug Metab. 2009, 10:68-78. 10.2174/138920009787048437.
3. Dinan T.G., Stanton C., Cryan J.F. Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 2013, 74(10):720-726.
4. Jayasimhan S., Yap N.Y., Roest Y., et al. Efficacy of microbial cell preparation in improving chronic constipation: a randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2013, 32(6):928-934.
5. Dickerson F.B., Stallings C., Origoni A., Katsafanas E., Savage C.L.G., Schweinfurth L.A.B., Goga J., Khushalani S., Yolken R.H. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim. Care Companion CNS Disord. 2014, 16(1). PCC.13m01579.
6. Guerra P.V., Lima L.N., Souza T.C., et al. Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial. World J. Gastroenterol. 2011, 17(34):3916-3921.
7. Bezirtzoglou E., Stavropoulou E. Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe 2011, 17(6):369-374. Epub 2011 Apr 16. 10.1016/j.anaerobe.2011.03.010.
8. Croxatto A., Prod'hom G., Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol. Rev. March 2012, 36(2):380-407.
9. Mogna L., Del Piano M., Deidda F., Nicola S., Soattini L., Debiaggi R., Sforza F., Strozzi G., Mogna G. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J. Clin. Gastroenterol. 2012, 46:S29-S32. 10.1097/MCG.0b013e31826852b7.
10. Tejero-Sariñena S., Barlow J., Costabile A., Gibson G.R., Rowland I. Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains?. Anaerobe 2013, 24:60-65. Epub 2013 Sep 30. 10.1016/j.anaerobe.2013.09.011.
11. Schoster A., Kokotovic B., Permin A., Pedersen P.D., Dal Bello F., Guardabassi L. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe 2013, 20:36-41. Epub 2013 Mar 5. 10.1016/j.anaerobe.2013.02.006.
12. Liévin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.-R., Servin A.L. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity gastrointestinal infection. Gut 2000, 47:646-652. 10.1136/gut.47.5.646.